Abstract
Nucleoside analogs are successful, widely used antiviral and anticancer therapeutics. Nucleotide prodrugs (i.e., pronucleotide) have increasingly been used to improve in vivo efficacy of nucleoside analogs. In this study, we evaluated the permeability of a series of phosphoramidate triester prodrugs of the anti-HIV drug 2′,3′-didehydro-2′,3′-dideoxythymidine across monolayers of Caco-2, Madin-Darby canine kidney (MDCKII) epithelial cell line, and its recombinant clone containing the human MDR1/P-gp gene (MDR1-MDCKII). Transport was studied in the apical-to-basolateral (A-B) and the basolateral-to-apical directions (B-A). The impact upon transport of differences in stereochemistry at the chiral phosphate center was evaluated. In the Caco-2 and MDCK models the A-B permeability was lower than expected based on the lipophilicity of the compounds, suggesting the involvement of a polarized efflux system and/or metabolic degradation in limiting the absorption of these ester-based prodrugs. Average permeability values through cell monolayers obtained in the A-B direction were lower than in the B-A direction. The inclusion of the P-glycoprotein (P-gp) inhibitor verapamil in the transport medium markedly increased the permeability in the A-B direction, whereas decreasing it in the opposite direction, suggesting an efflux mechanism mainly mediated by P-gp. Stereoselective permeability was significant for the most lipophilic compounds, where the diastereoisomer possessing the slower eluting time on a reverse-phase high-performance liquid chromatography column was transported through Caco-2 and MDCK monolayers at higher rate.
Footnotes
-
This study was supported by the Biotechnology and Biological Sciences Research Council.
-
DOI: 10.1124/jpet.103.056135.
-
ABBREVIATIONS: ddN, 2′,3′-dideoxynucleoside analogs; HIV, human immunodeficiency virus; AAM, amino acyl metabolite; d4T, 2′,3′-didehydro-2′,3′-dideoxythymidine; MDCK, Madin-Darby canine kidney; DMEM, Dulbecco's modified Eagle's medium; PMSF, phenylmethylsulfonyl fluoride; TEER, transepithelial electrical resistance; A-B, apical to basolateral; B-A, basolateral to apical; DMSO, dimethyl sulfoxide; P-gp, P-glycoprotein; HPLC, high-performance liquid chromatography; LC-MS, liquid chromatography-mass spectrometry; FE, fast eluting; SE, slow eluting.
- Received June 25, 2003.
- Accepted September 2, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|